soman has been researched along with Encephalopathy, Toxic in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 11 (55.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dao, TT; Devorak, JL; Kan, RK; Leuschner, JA; Perkins, MW; Rodriguez, A; Sciuto, AM; Wong, B | 1 |
| Albuquerque, EX; Aracava, Y; Gullapalli, RP; Helal Neto, E; Makris, G; Merchenthaler, I; Pereira, EF; Wang, J; Zhuo, J | 1 |
| Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Figueiredo, TH; Qashu, F; Souza, AP | 1 |
| Karasova, JZ; Kassa, J; Kuca, K; Musilek, K; Tesarova, S | 1 |
| Langston, JL; Myers, TM | 1 |
| Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Ferrara, TM; Figueiredo, TH; Pidoplichko, V; Qashu, F; Stevens, D | 1 |
| Joosen, MJ; Philippens, IH; van Helden, HP | 1 |
| Karasova, JZ; Kassa, J; Tesarova, S | 1 |
| Auta, J; Brown, A; Doctor, BP; Guiodotti, A; Jensen, N; Nambiar, MP; Oguntayo, S; Wang, Y; Wei, Y; Wood, E | 1 |
| Chen, C; Hu, XZ; Jacobowitz, DM; Lyman, M; Marini, AM; McDonough, J; Pan, H; Van Shura, K | 1 |
| Chanda, S; de Araujo Furtado, M; Rossetti, F; Yourick, D | 1 |
| Newmark, J | 1 |
| Adani, R; Amitai, G; Dachir, S; Fishbein, E; Laish, I; Meshulam, H | 1 |
| Bellier, B; Breton, P; Daulon, S; Delamanche, S; Taysse, L | 1 |
| Gordon, RK; Nambiar, MP; Ratcliffe, RH; Rezk, PE; Steele, KE; Tetz, LM | 1 |
| Armstrong, S; Mumford, H; Price, M; Scott, L; Wetherell, J | 1 |
| Cohen, O; Kronman, C; Mazor, O; Ordentlich, A; Raveh, L; Shafferman, A | 1 |
| Karasova, J; Kassa, J | 1 |
| Baille, V; Carpentier, P; Delacour, C; Denis, J; Dorandeu, F; Foquin, A; Job, A; Pouyatos, B | 1 |
| Carpentier, P; de Groot, DM; Foquin, A; Lallement, G; Lerner-Natoli, M; Rondouin, G | 1 |
3 review(s) available for soman and Encephalopathy, Toxic
| Article | Year |
|---|---|
Non-enzymatic pretreatment of nerve agent (soman) poisoning: a brief state-of-the-art review.
Topics: Animals; Antidotes; Brain; Chemical Warfare Agents; Cholinesterase Inhibitors; Drug Therapy, Combination; Humans; Neurotoxicity Syndromes; Protein Binding; Receptors, Cholinergic; Receptors, Glutamate; Soman | 2011 |
Exposure to nerve agents: from status epilepticus to neuroinflammation, brain damage, neurogenesis and epilepsy.
Topics: Animals; Anticonvulsants; Antidotes; Brain; Brain Waves; Chemical Warfare Agents; Cholinesterase Inhibitors; Disease Models, Animal; Electroencephalography; Encephalitis; Epilepsy; Humans; Neurogenesis; Neuroprotective Agents; Neurotoxicity Syndromes; Soman | 2012 |
Therapy for nerve agent poisoning.
Topics: Antidotes; Atropine; Chemical Warfare Agents; Humans; Neurotoxicity Syndromes; Neurotoxins; Organophosphate Poisoning; Organophosphates; Organothiophosphorus Compounds; Pralidoxime Compounds; Pyridostigmine Bromide; Sarin; Soman | 2004 |
17 other study(ies) available for soman and Encephalopathy, Toxic
| Article | Year |
|---|---|
Vapor inhalation exposure to soman in conscious untreated rats: preliminary assessment of neurotoxicity.
Topics: Acetylcholinesterase; Administration, Inhalation; Animals; Body Weight; Brain; Chemical Warfare Agents; Male; Neurotoxicity Syndromes; Rats, Sprague-Dawley; Soman | 2016 |
Magnetic resonance imaging reveals that galantamine prevents structural brain damage induced by an acute exposure of guinea pigs to soman.
Topics: Animals; Brain; Brain Mapping; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Female; Galantamine; Gene Expression Regulation; Guinea Pigs; Magnetic Resonance Imaging; Neurogranin; Neurotoxicity Syndromes; Nootropic Agents; RNA, Messenger; Soman; Time Factors | 2010 |
Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology.
Topics: Amygdala; Animals; Cholinesterase Inhibitors; Disease Models, Animal; Disease Susceptibility; Fluoresceins; Hippocampus; Male; Nerve Degeneration; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawley; Seizures; Soman; Time Factors | 2010 |
A comparison of the ability of newly-developed bispyridinium oxime K203 and currently available oximes (trimedoxime, obidoxime, HI-6) to counteract the acute neurotoxicity of soman in rats.
Topics: Animals; Atropine; Behavior, Animal; Chemical Warfare Agents; Drug Therapy, Combination; Male; Motor Activity; Neuroprotective Agents; Neurotoxicity Syndromes; Oximes; Pyridinium Compounds; Rats; Rats, Wistar; Soman | 2010 |
Diet composition exacerbates or attenuates soman toxicity in rats: implied metabolic control of nerve agent toxicity.
Topics: Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Body Weight; Chemical Warfare Agents; Choline; Diet; Diet, Ketogenic; Dietary Sucrose; Disease Models, Animal; Glucose; Lethal Dose 50; Male; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawley; Soman; Time Factors | 2011 |
Neuroprotective efficacy of caramiphen against soman and mechanisms of its action.
Topics: Animals; Behavior, Animal; Brain; Cell Count; Chemical Warfare Agents; Cyclopentanes; Dose-Response Relationship, Drug; Male; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Seizures; Soman; Synaptic Potentials | 2011 |
A comparison of the neuroprotective efficacy of individual oxime (HI-6) and combinations of oximes (HI-6+trimedoxime, HI-6+K203) in soman-poisoned rats.
Topics: Animals; Behavior, Animal; Drug Therapy, Combination; Male; Molecular Structure; Motor Activity; Neuroprotective Agents; Neurotoxicity Syndromes; Oximes; Pyridinium Compounds; Rats; Rats, Wistar; Soman; Trimedoxime | 2011 |
Neuroprotective effects of imidazenil against chemical warfare nerve agent soman toxicity in guinea pigs.
Topics: Acetylcholinesterase; Analysis of Variance; Animals; Atropine; Benzodiazepines; Body Weight; Brain; Chemical Warfare Agents; Cholinesterase Reactivators; Disease Models, Animal; Drug Administration Schedule; Electrocardiography; Electroencephalography; Guinea Pigs; Imidazoles; Lethal Dose 50; Male; Muscarinic Antagonists; Neuroprotective Agents; Neurotoxicity Syndromes; Pralidoxime Compounds; Seizures; Soman; Telemetry; Time Factors | 2012 |
Alpha-linolenic acid is a potent neuroprotective agent against soman-induced neuropathology.
Topics: alpha-Linolenic Acid; Analysis of Variance; Animals; Brain Injuries; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Electrophoretic Mobility Shift Assay; Fluoresceins; Male; Nerve Degeneration; Neuroprotective Agents; Neurotoxicity Syndromes; NF-kappa B; Organic Chemicals; Rats; Rats, Sprague-Dawley; Soman | 2012 |
Bifunctional compounds eliciting anti-inflammatory and anti-cholinesterase activity as potential treatment of nerve and blister chemical agents poisoning.
Topics: Animals; Anti-Inflammatory Agents; Blister; Cholinesterase Inhibitors; Cholinesterases; Edema; Mice; Neurotoxicity Syndromes; Soman; Survival Rate | 2005 |
Protection against soman-induced neuropathology and respiratory failure: a comparison of the efficacy of diazepam and avizafone in guinea pig.
Topics: Animals; Anticonvulsants; Atropine; Brain; Cholinesterase Inhibitors; Diazepam; Dipeptides; Electroencephalography; Guinea Pigs; Neuroprotective Agents; Neurotoxicity Syndromes; Respiratory Insufficiency; Soman | 2006 |
Development of a rat pilocarpine model of seizure/status epilepticus that mimics chemical warfare nerve agent exposure.
Topics: Animals; Anticonvulsants; Behavior, Animal; Body Temperature; Brain; Chemical Warfare Agents; Cholinergic Antagonists; Drug Evaluation, Preclinical; Electroencephalography; Heart Rate; Lethal Dose 50; Lithium Chloride; Male; Models, Animal; Motor Activity; Muscarinic Agonists; N-Methylscopolamine; Neuroprotective Agents; Neurotoxicity Syndromes; Pilocarpine; Rats; Rats, Sprague-Dawley; Seizures; Soman; Status Epilepticus | 2006 |
Development of next generation medical countermeasures to nerve agent poisoning.
Topics: Animals; Antidotes; Atropine; Chemical Warfare Agents; Dipeptides; Disease Models, Animal; Drug Therapy, Combination; Guinea Pigs; Ileal Diseases; Intussusception; Lethal Dose 50; Male; Neurotoxicity Syndromes; Oximes; Physostigmine; Pyridinium Compounds; Scopolamine Derivatives; Soman; Time Factors | 2007 |
Polyethylene-glycol conjugated recombinant human acetylcholinesterase serves as an efficacious bioscavenger against soman intoxication.
Topics: Acetylcholinesterase; Animals; Antibodies; Cell Line; Cholinesterase Inhibitors; Cloning, Molecular; Drug Carriers; Enzyme-Linked Immunosorbent Assay; Half-Life; Humans; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Neuroprotective Agents; Neurotoxicity Syndromes; Polyethylene Glycols; Recombinant Proteins; Soman; Substrate Specificity | 2007 |
A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) to counteract soman-induced neurotoxicity in rats.
Topics: Animals; Antidotes; Atropine; Autonomic Nervous System; Behavior, Animal; Butanes; Chemical Warfare Agents; Cholinesterase Reactivators; Drug Therapy, Combination; Male; Motor Activity; Neuroprotective Agents; Neurotoxicity Syndromes; Obidoxime Chloride; Oximes; Pyridinium Compounds; Rats; Rats, Wistar; Soman; Structure-Activity Relationship | 2007 |
Distortion product otoacoustic emissions as non-invasive biomarkers and predictors of soman-induced central neurotoxicity: a preliminary study.
Topics: Acoustic Stimulation; Animals; Audiometry; Audiometry, Evoked Response; Brain; Brain Chemistry; Cholinesterase Inhibitors; Cochlea; Injections, Subcutaneous; Male; Neurotoxicity Syndromes; Otoacoustic Emissions, Spontaneous; Rats; Rats, Wistar; Severity of Illness Index; Soman; Survival Analysis; Time Factors | 2007 |
Effects of atropine sulphate on seizure activity and brain damage produced by soman in guinea-pigs: ECoG correlates of neuropathology.
Topics: Animals; Atropine; Brain; Cholinesterase Inhibitors; Convulsants; Electroencephalography; Guinea Pigs; Male; Muscarinic Antagonists; Neurotoxicity Syndromes; Pyridostigmine Bromide; Seizures; Soman | 2000 |